Haoxi Health Technology Limited (HAO)

Haoxi Health Technology Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	32.8	48.52	28.23	16.16	12.85
Revenue Growth (YoY)	-32.39%	71.88%	74.72%	25.76%	-
Cost of Revenue	31.88	45.77	26.17	15.51	12.24
Gross Profit	0.93	2.75	2.06	0.65	0.61
Selling, General & Admin	2.85	0.95	0.81	0.28	0.21
Research & Development	0.08	0.08	0.06	0.1	0.06
Operating Expenses	2.93	1.03	0.87	0.38	0.28
Operating Income	-2	1.72	1.2	0.27	0.33
Interest Expense	-0.05	-0.04	-0.02	-0.01	-0
Interest & Investment Income	0.36	0.08	-	-	-
Other Non Operating Income (Expenses)	5.83	-0.02	0.02	0	-0
Pretax Income	4.15	1.74	1.19	0.26	0.33
Income Tax Expense	0.27	0.44	0.22	0.02	0.02
Net Income	3.88	1.29	0.97	0.24	0.3
Net Income to Common	3.88	1.29	0.97	0.24	0.3
Net Income Growth	200.13%	33.20%	296.49%	-19.56%	-
Shares Outstanding (Basic)	2	1	1	1	1
Shares Outstanding (Diluted)	2	1	1	1	1
Shares Change (YoY)	95.84%	10.82%	10.45%	-	-
EPS (Basic)	1.66	1.06	0.88	0.24	0.30
EPS (Diluted)	1.32	1.06	0.87	0.24	0.30
EPS Growth	25.32%	21.30%	255.70%	-19.56%	-
Free Cash Flow	-3.36	-0.8	-0.92	-0.68	2.65
Free Cash Flow Per Share	-1.40	-0.66	-0.83	-0.68	2.65
Gross Margin	2.83%	5.67%	7.31%	4.01%	4.71%
Operating Margin	-6.10%	3.54%	4.24%	1.66%	2.57%
Profit Margin	11.82%	2.66%	3.44%	1.51%	2.37%
Free Cash Flow Margin	-10.24%	-1.65%	-3.25%	-4.23%	20.59%
EBITDA	-1.71	1.73	1.2	0.27	0.33
EBITDA Margin	-5.20%	3.56%	4.27%	1.68%	2.58%
D&A For EBITDA	0.29	0.01	0.01	0	0
EBIT	-2	1.72	1.2	0.27	0.33
EBIT Margin	-6.10%	3.54%	4.24%	1.66%	2.57%
Effective Tax Rate	6.53%	25.56%	18.54%	5.78%	6.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q